Hepatodoron¿ tablets, 200 pcs — FDA record F-0820-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 4, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Hepatodoron¿ tablets, 200 pcs
Reason
Dietary supplement may contain metal
Classification
Class II
Recalling firm
Weleda Inc
Quantity
890 units
Agency-reported status
Terminated
Source record identifier
F-0820-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityArt.-No. 00326500/003265xx Batch no: J033 Expiry date: January 31, 2027

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

nationwide

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
May 10, 2023
Recall initiation date
Apr 4, 2023
Center classification date
May 4, 2023
Termination date
Dec 13, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records